KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Enterprise Value: 2009-2025

Historic Enterprise Value for Ionis Pharmaceuticals (IONS) over the last 17 years, with Sep 2025 value amounting to $8.2 billion.

  • Ionis Pharmaceuticals' Enterprise Value rose 142.66% to $8.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 144.86%. This contributed to the annual value of $3.2 billion for FY2024, which is 34.60% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Enterprise Value of $8.2 billion as of Q3 2025, which was up 104.76% from $4.0 billion recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Enterprise Value ranged from a high of $8.2 billion in Q3 2025 and a low of $2.2 billion during Q4 2021.
  • Its 3-year average for Enterprise Value is $4.2 billion, with a median of $4.0 billion in 2025.
  • In the last 5 years, Ionis Pharmaceuticals' Enterprise Value tumbled by 63.71% in 2021 and then skyrocketed by 142.66% in 2025.
  • Ionis Pharmaceuticals' Enterprise Value (Quarterly) stood at $2.2 billion in 2021, then soared by 54.83% to $3.4 billion in 2022, then spiked by 45.84% to $4.9 billion in 2023, then plummeted by 34.60% to $3.2 billion in 2024, then surged by 142.66% to $8.2 billion in 2025.
  • Its Enterprise Value was $8.2 billion in Q3 2025, compared to $4.0 billion in Q2 2025 and $2.7 billion in Q1 2025.